会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • Nb-Sn phase superconducting wire and precursor wire thereof
    • Nb-Sn相超导线及其母线
    • US20070004597A1
    • 2007-01-04
    • US11156581
    • 2005-06-21
    • Yoshio KuboTakanori Sone
    • Yoshio KuboTakanori Sone
    • H01L39/24
    • H01L39/14H01L39/2409
    • The Nb-Sn phase superconducting wire 15 elongating in the longitudinal direction and having a cross section including a core part and a shell part surrounding of the core part. The wire 15 includes a core part made of only bronze 17 and a shell part including: a matrix made of bronze 17; and Nb3Sn filaments 16 embedded in the bronze, wherein the Nb3Sn filaments 16 are radially arranged and electromagnetically and radially coupled to one another in the radius direction of the wire 15 in the surrounding of the core part, and wherein the Nb3Sn filaments 16 have larger diameters toward the outside, and the Nb3Sn filaments 16 are kept at spacing so as to electromagnetically isolated from one another in the circumferential direction of the wire 15.
    • Nb-Sn相超导线15在长度方向上延伸并且具有包括芯部的芯部和围绕芯部的壳部的截面。 线15包括仅由青铜17制成的芯部和壳部,包括:由青铜17制成的基体; 和包含在青铜中的Nb 3 Sn丝16,其中,Nb 3 Sn丝16径向布置并且在线的半径方向上彼此电磁和径向耦合 15,并且其中,Nb 3 Sn丝16具有朝向外部的较大直径,并且Nb 3 Sn丝16保持间隔距离 以在电线15的圆周方向上彼此电磁隔离。
    • 5. 发明授权
    • 3-Aminoindazole derivatives
    • 3-氨基吲唑衍生物
    • US4474964A
    • 1984-10-02
    • US569524
    • 1984-01-09
    • Tadayuki IbukiTaisuke SugiharaHiromu KawakuboTakanori Sone
    • Tadayuki IbukiTaisuke SugiharaHiromu KawakuboTakanori Sone
    • C07D231/56C07D295/092C07D401/12C07D403/12
    • C07D231/56C07D295/088
    • A compound of the formula (I): ##STR1## wherein W.sub.1 is a hydrogen atom or a ##STR2## group wherein Y is a C.sub.1-6 alkylene group or a C.sub.1-6 alkylene group having a C.sub.1-6 alkyl group substituent; and R.sub.1 and R.sub.2 each independently is a hydrogen atom or a C.sub.1-6 alkyl group and R.sub.1 and R.sub.2 may form a C.sub.4-6 heterocyclic ring or a nitrogen-containing C.sub.4-6 heterocyclic ring together with the adjacent nitrogen atom and the C.sub.4-6 heterocyclic rings may have at least one C.sub.1-6 alkyl group, hydroxyl group or halogen atom;W.sub.2 is a hydrogen atom or a ##STR3## group wherein Z is a C.sub.1-6 alkylene group or a C.sub.1-6 alkylene group having a C.sub.1-6 alkyl group substituent; and R.sub.3 and R.sub.4 each independently is a hydrogen atom or a C.sub.1-6 alkyl group and R.sub.3 and R.sub.4 may form a C.sub.4-6 heterocyclic ring or a nitrogen-containing C.sub.4-6 heterocyclic ring together with the adjacent nitrogen atom and the C.sub.4-6 heterocyclic rings may have at least one C.sub.1-6 alkyl group, hydroxyl group or halogen atom;when W.sub.1 is a hydrogen atom, W.sub.2 is the ##STR4## group; and when W.sub.2 is a hydrogen atom, W.sub.1 is the ##STR5## group; and the pharmaceutically acceptable acid addition salt thereof having antiinflammatory, analgesic and digestive tract ulcer suppressing activity.
    • 式(I)的化合物:其中W1是氢原子或其中Y是C1-6亚烷基或具有C1-6烷基的C1-6亚烷基的基团 取代基; 并且R 1和R 2各自独立地为氢原子或C 1-6烷基,并且R 1和R 2可以与相邻的氮原子一起形成C 4-6杂环或含氮的C 4-6杂环,并且C 4-6 杂环可以具有至少一个C 1-6烷基,羟基或卤素原子; W2是氢原子或其中Z是C1-6亚烷基或具有C1-6烷基取代基的C1-6亚烷基的基团; 并且R 3和R 4各自独立地为氢原子或C 1-6烷基,并且R 3和R 4可以与相邻的氮原子一起形成C 4-6杂环或含氮的C 4-6杂环,且C 4-6 杂环可以具有至少一个C 1-6烷基,羟基或卤素原子; 当W1是氢原子时,W2是组; 当W2是氢原子时,W1是组; 和其药学上可接受的酸加成盐具有抗炎,止痛和消化道溃疡抑制活性。